Home
Pipeline
ColiFinĀ®
Inhaled Murepavadin
Balixafortide
Lonodelestat (external)
Breakthrough Platforms
Partnering
About us
Investor Relations
Corporate Governance*
Reporting*
Corporate Presentation
Share Information
Media Releases
Ad-hoc Releases
Calendar
Contact
Careers
Contact
News on home
Spexis
>
News on home
Latest news
Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
Spexis provides business update and announces financial results for the full year 2022
See all news
This site uses cookies:
Find out more.
Accept